No argument on the implications of that article, in fact might border on impressive details of a possible future. Only caveat is why the share price trades with such low volume most days. Strange circumstances in that there are such high potentials on the one hand and so little interest on the other. Has to make one wonder...........something big coming soon ?
I'm sure that you have all read this article but here is the URL. It is what encouraged me to buy into this co.
Privately-held Adapt Pharma submits a New Drug Application (NDA) to the FDA seeking approval for Fast Track-designated Narcan (naloxone) Nasal Spray for the treatment of opioid overdose. If approved, Narcan will be the first non-injectable opioid antidote available for sale. Its formulation will make it a much-preferred option for community settings where most overdoses occur.According to the CDC, there were ~24,500 opioid overdose deaths in the U.S. in 2013.
The FDA has 60 days to approve or disapprove this medication.
Been wondering that for a while, I believe if they receive FDA approval it will be mandatory that every police, ambulance, school etc.. carry the opioid overdose nasal spray.
I do agree with you and have been in this stock for a time. The weekly graph on this is very encouraging, what is not encouraging is the lack of daily volume (sometimes). Other than that I can see no reasons why this won't be a big time stock in the future.